Related Experiment Video
Updated: May 30, 2026
09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis
1Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, London, UK.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|August 2, 2011
Summary
Cognitive impairment in primary progressive multiple sclerosis (PPMS) is linked to brain imaging. Grey matter integrity, measured by magnetization transfer ratio (MTR), is key for overall cognitive function in PPMS patients.
Area of Science:
- Neuroimaging
- Neurology
- Cognitive Science
Background:
- Primary progressive multiple sclerosis (PPMS) is a debilitating neurological condition.
- Cognitive impairment is a common and significant symptom in PPMS patients.
- Understanding the relationship between brain structure and cognitive decline is crucial for managing PPMS.
Purpose of the Study:
- To investigate the associations between specific cognitive impairments and various magnetic resonance imaging (MRI) measures in patients with PPMS.
- To identify which imaging markers best predict cognitive dysfunction in PPMS.
Main Methods:
- A cross-sectional study involving 27 PPMS patients and 31 healthy controls.
- Neuropsychological testing was conducted to assess cognitive functions.
- Brain MRI, including conventional sequences, volumetric scans, and magnetization transfer (MT) imaging, was performed.
Main Results:
- PPMS patients exhibited deficits in attention, processing speed, verbal memory, and executive functions compared to controls.
- Lower grey matter (GM) magnetization transfer ratio (MTR) correlated with worse overall cognitive performance.
- Normal-appearing white matter (NAWM) volume was associated with attention/processing speed, while T2 lesion load (T2LL) related to verbal memory.
Conclusions:
- Comprehensive MRI assessments of both GM and white matter (WM) are recommended for predicting cognitive impairment in PPMS.
- GM MTR is a significant indicator of overall cognitive dysfunction in PPMS, highlighting the importance of GM integrity.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:25Secondary Spinal Cord Injury llI: Pathophysiology
Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...